Meeting
2021 ASCO Annual Meeting
The influence of harvest method on dendritic cell function and clinical outcomes in a randomized trial of a dendritic cell vaccine to prevent recurrences in high-risk melanoma.
Authors
Alexandra Adams
Brooke Army Medical Center, Fort Sam Houston, TX
Alexandra Adams , G. Travis Clifton , Timothy J. Vreeland , Anne E. O'Shea , Patrick M. McCarthy , Robert Connor Chick , Phillip M. Kemp Bohan , Annelies Hickerson , Diane F. Hale , John Robert Hyngstrom , Adam C. Berger , James W. Jakub , Jeffrey J. Sussman , Montaser F. Shaheen , Thomas Wagner , Mark B Faries , George Earl Peoples
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT02301611
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9548)
DOI
10.1200/JCO.2021.39.15_suppl.9548
Abstract #
9548
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an autologous tumor lysate + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC and embedded phase I/IIa trial with tumor lysate particle only (TLPO) vaccine in stage III and stage IV (resected) melanoma to prevent recurrence.
First Author: John W Myers
Poster
2015 ASCO Annual Meeting
Final pre-specified analysis of the phase II trial of the AE37+GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.
First Author: Julia M. Greene
Poster
2023 ASCO Annual Meeting
A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2–positive breast cancer.
First Author: Hyo S. Han
Poster
2023 ASCO Annual Meeting
Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis.
First Author: Ajitha Kommalapati